Private equity funds are pouring hundreds of millions of dollars into Kerala’s healthcare sector, reshaping a system long dominated by inde...

Cloudnine Hospitals is set to acquire Apollo Cradle and Apollo Fertility. This strategic move will create India's largest maternity and chi...

Siemens Healthineers is exiting its Indian cancer care chain, American Oncology Institute. The deal is valued between ₹1,500-2,000 crore. P...

Indian law firms are busier than ever, advising on thousands of deals worth billions. This activity spans mergers, private equity, and vent...

Global lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co....

KKR, the prominent US investment firm, has committed another ₹1,750 crore to Baby Memorial Hospital, elevating their overall investment to ...

Asia Healthcare Holdings has appointed Venkatesh Tarakkad as its new Chief Financial Officer and Head of Business Development. Tarakkad bri...

Sun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...

Baby Memorial Hospital will acquire around 60% stake in the Hyderabad hospital chain's parent company, Unimed Healthcare.

Novo Holdings, a major investment firm, has acquired a 49% stake in Surya Hospitals for an estimated Rs 1,000-1,200 crore. This strategic m...

Aster DM Healthcare has finalized the acquisition of a 5% stake in Quality Care India Ltd (QCIL) through a share swap with BCP Asia II TopC...

The companies announced the proposed merger in a joint statement in December 2018.

Outbound acquisitions by Indian companies were mainly from the energy & power sector with a deal value of $2.2 billion.

Growing cash reserves indicates possibilities for mergers and acquisitions in global healthcare technology industry, says a Frost & Sulliva...

M&A deals in healthcare IT sector have been picking up in the last three years, the report said.

'Besides inorganic initiatives, the industry is also stepping up its organic investments.'

India will see the largest number of M&As in pharmaceutical and healthcare sector this year despite regulations, according to Grant Thornto...